Please assess the completion status of the following clinical trial:

Trial Title: FilmArray Pneumonia Panel for Antimicrobial Treatment of HAP/VAP in Intensive Care Units

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: FACTORIAL
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Aged 19 years or older~2. Diagnosed with hospital-acquired or ventilator-associated pneumonia and being treated in an intensive care unit~3. Patient or his/her legal proxy agrees to participate and is able to provide informed consent~Exclusion Criteria:~1. Has been treated with antibiotic for HAP/VAP for 24 hr or longer~2. Requires antibiotic treatment for indications other than HAP/VAP~3. Bacteria has been isolated from respiratory specimens within 7 days prior to screening~4. Immunocompromised host whose major differential diagnosis includes Pneumocystis jirovecii or cytomegalovirus pneumonia~5. Expected to die within 2 days since screening due to underlying disease~6. Has an advance directive against mechanical ventilation or cardiopulmonary resuscitation~7. Does not want to participate or unable to provide consent~8. Determined to be unfit by the study investigator

- Gender: ALL
- Minimum Age: 19 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Intervention (Type: ACTIVE_COMPARATOR): Respiratory specimens from the subjects are tested by the FilmArray Pneumonia panel and the results are reported via an electronic health record system. Treating physicians may adjust empirical antibiotic regimens with assistance from the guidelines formulated by the study investigators. Other microbiologic tests, including cultures, are performed as per routine practice.
- Control (Type: NO_INTERVENTION): Microbiologic tests, including cultures, are performed as per routine practice. No intervention is made on the antimicrobial treatment in the control arm.

Based on this trial design, predict the completion outcome and termination type (if applicable).